Comparing Bevacizumab vs Zejula
| Bevacizumab Remove Bevacizumab from your drug comparison | Zejula Remove Zejula from your drug comparison |
|
|---|
| Bevacizumab Remove Bevacizumab from your drug comparison | Zejula niraparib Remove Zejula from your drug comparison |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Cervical Cancer, Fallopian Tube Cancer, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
Prescribed for Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer. Zejula may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Ovarian Cancer
Popular Comparisons
|
|||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & Reviews |
|||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
See the full bevacizumab side effects document. |
Common side effects include: anemia, asthenia, constipation, cough, decreased hemoglobin, decreased neutrophils, decreased platelet count, decreased white blood cell count, dizziness, dyspnea, fatigue, headache, hypertension, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, insomnia, mucositis, nasopharyngitis, nausea, neutropenia, palpitations, skin rash, stomatitis, thrombocytopenia, vomiting, decreased appetite, dysgeusia, and xerostomia. See the full Zejula side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Zejula prices |
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
| N/A |
|
||||||||
Brand Names |
|||||||||
| Avastin, Mvasi, Zirabev |
N/A |
||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
480 hours |
51 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Summary unavailable. See the full Pregnancy Warnings document. |
||||||||
Drug Interactions |
|||||||||
|
A total of 23 drugs are known to interact with bevacizumab:
|
A total of 403 drugs are known to interact with Zejula:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
N/A |
March 27, 2017 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Patient resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
|
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.